MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 29.96
+0.14 (0.47%)
Nov 12, 2026, 10:04 AM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €1.08 billion as of November 11, 2026. It is the 9,144th most valuable company in the world and the 132nd biggest in France. Its market cap has increased by 8.51% in one year.
Market Cap
1.08B
Enterprise Value
1.06B
Revenue
24.28M
Global Rank
Country Rank
#132 France
PE Ratio
n/a
ChartMarket Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 1.08B, an increase of 636.39%. That is a compound annual growth rate of 27.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.08B | 28.98% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.00B |
| Nanobiotix | 1.47B |
| Inventiva | 793.90M |
| DBV Technologies | 630.29M |
| Genfit | 531.33M |
| Valneva SE | 492.95M |
| Valerio Therapeutics Société anonyme | 237.24M |
| Transgene | 206.78M |